Media

April 29, 2025: AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncology – Pharmaphorum

Date : April 29, 2025

Lien vers le média

April 28, 2025: MaaT Pharma Presents Preclinical Data at AACR Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034

May 12, 2025: MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)